Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05273996 · ClinicalTrials.gov registry record · Phase 4
Predictors of Cognitive Outcomes in Geriatric Depression
A Phase 4 study of Major Depressive Disorder and Stress, sponsored by David Steffens.
- Active
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT05273996 is a Phase 4 study of Major Depressive Disorder and Stress that is active but no longer recruiting, run by David Steffens. The registered enrollment target is 75 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05273996, a Phase 4 study of Major Depressive Disorder and Stress, is active but no longer recruiting, sponsored by David Steffens.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will focus on examining effects of stress on long-term mood and cognitive outcomes of late-life depression. It will also example the neural underpinnings of these changes using structural and functional brain imaging. Understanding how effects of stress in older depressed adults, as well as factors that might minimize those effects, lead to particular mood and cognitive outcomes will inform future development of novel prevention strategies.
Conditions Studied
Interventions
- DRUG Sertraline, bupropion, desvenlafaxine
Study Locations (1)
Connecticut
- UConn Health - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-09-28 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05273996
The ClinicalTrials.gov registry entry for NCT05273996 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (80% lower). The listed sponsor is David Steffens, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Sertraline, bupropion, desvenlafaxine is the first listed.
NCT05273996 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05273996 about?
NCT05273996 is a clinical study titled "Predictors of Cognitive Outcomes in Geriatric Depression". This study will focus on examining effects of stress on long-term mood and cognitive outcomes of late-life depression. It will also example the neural underpinnings of these changes using structural and functional brain imaging. Understanding how effects of stress in older depressed adults, as well ...
What is the current status of trial NCT05273996?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2021-09-28. Estimated completion is 2026-06-30.
What conditions does trial NCT05273996 study?
This clinical trial studies the following conditions: Major Depressive Disorder, Stress, Cognitive Change, Neuroticism.
What interventions are being tested in trial NCT05273996?
The interventions under investigation include: Sertraline, bupropion, desvenlafaxine (DRUG).
Who is sponsoring clinical trial NCT05273996?
This trial is sponsored by David Steffens, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05273996 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
-
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
RECRUITING · Phase 4
-
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
RECRUITING · Phase 4
-
Neural Circuit Effects of Ketamine in Depression
RECRUITING · Phase 4
-
Aβ Dynamics in LLMD
RECRUITING · Phase 4
-
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.